Huelsenbeck, SC; Huelsenbeck, J; Fritz, G
Lovastatin protects cardiomyoblasts from doxorubicin-induced cytotoxicity by antagonizing topoisomerase II cleavable complex formationNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 383. 2011 S. 49-49
Nilsson, S; Huelsenbeck, J; Fritz, G
Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cellsCANCER LETTERS. Bd. 304. H. 1. 2011 S. 60-69
Christmann, M; Verbeek, B; Roos, WP et al.
O-6-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: Enzyme activity, promoter methylation and immunohistochemistryBIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. Bd. 1816. H. 2. 2011 S. 179-190
Christmann, M; Kaina, B
O(6)-methylguanine-DNA methyltransferase (MGMT): impact on cancer risk in response to tobacco smokeMutation Research. 2011 S. 1-11
Fritz, G; Henninger, C; Huelsenbeck, J
Potential use of HMG-CoA reductase inhibitors (statins) as radioprotective agentsBRITISH MEDICAL BULLETIN. Bd. 97. H. 1. 2011 S. 17-26
Hamalukic, M; Huelsenbeck, J; Schad, A et al.
Rac1-Regulated Endothelial Radiation Response Stimulates Extravasation and Metastasis That Can Be Blocked by HMG-CoA Reductase InhibitorsPLOS ONE. Bd. 6. H. 10. 2011 S. -
Quiros, S; Roos, WP; Kaina, B
Rad51 and BRCA2-New Molecular Targets for Sensitizing Glioma Cells to Alkylating Anticancer DrugsPLOS ONE. Bd. 6. H. 11. 2011 S. -
Kuppers, M; Faust, D; Linz, B et al.
Regulation of ERK-1/2 activity upon contact inhibition in fibroblastsBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. Bd. 406. H. 3. 2011 S. 483-487
Reichert, S; Rodel, C; Mirsch, J et al.
Survivin inhibition and DNA double-strand break repair: A molecular mechanism to overcome radioresistance in glioblastomaRADIOTHERAPY AND ONCOLOGY. Bd. 101. H. 1. 2011 S. 51-58
Osmak, M; Cimbora-Zovko, T; Brozovic, A et al.
Synthesis and biological evaluation of 4-nitro-substituted 1,3-diaryltriazenes as a novel class of potent antitumor agentsFEBS JOURNAL. Bd. 278. 2011 S. 333-333